Clear The Air News Tobacco Blog Rotating Header Image

E-cigarettes

Health groups ask FDA to ban candy-flavoured e-liquids

Candy- and fruit-flavoured tobacco products including e-cigarettes and cigars are luring youth into nicotine addiction, according to a report sponsored by leading health organisations that asks they be banned.

http://www.tobaccojournal.com/Health_groups_ask_FDA_to_ban_candy-flavoured_e-liquids.54145.0.html

Food and Drug Administration (FDA) authorities should ban all flavoured tobacco products, says the report issued by the Campaign for Tobacco-Free Kids, American Academy of Pediatrics, American Cancer Society Cancer Action Network, American Heart Association and American Lung Association.

“Gummy bear, cotton candy, peanut butter cup, cookies ‘n cream and pop rocks for e-cigarettes and chocolate, wild berry, watermelon, lemonade and cherry dynamite for cigars,” are some of the flavours targeted in the report.

Letter from New Zealand Associate Minister of Health on e-cigarette Regulations

Download (PDF, 565KB)

Vapors Of High-Powered E-Cigarettes May Cause Cancer

http://www.sciencetimes.com/articles/10054/20170309/vapors-of-high-powered-e-cigarettes-may-cause-cancer.htm

People might have to stop powering their e-cigarettes to the highest level as scientists have found out that its vapors can cause cancer. There are significant levels of cancer-causing benzene in the vapors of those e-cigarettes in the highest power, stated Portland State University scientists.

The result of the study was published on March 8 in the online journal “PLOS ONE”. The chemistry professor James F. Pankow led the research team, reported EurekAlert. The level of benzene they found from the high powered e-cigarettes was thousand times higher than in the surrounding air. It also depends greatly on the device itself. If it is not at its highest level, the benzene levels are not that high.

When the e-cigarette fluid additive chemicals benzoic acid or benzaldehyde is present it added so much to the benzene levels. However, of course, the level of this is nothing compared to the level of a conventional smoke from a cigarette. Benzene is one component of gasoline. It is very bad for people.

It has been linked to a number of illnesses that are very grave and can cause death. Diseases like leukemia and bone marrow failure are few of the examples of diseases a person can acquire with benzene. Benzene is usually found in the urban areas where industrial emissions are very rampant plus fuel tank leaks. This chemical has been deemed as the largest single cancer-risk air component in the U.S.

Meanwhile, according to Science Daily, the smoke that conventional cigarettes release is affecting the natural healing process of lungs. The blocking then leads to chronic obstructive pulmonary disease or COPD. Cough, bronchitis and breathing difficulties are the major signs of COPD. The findings were published in “American Journal of Respiratory and Critical Care Medicine”. It was from the researchers at the Helmholtz Zentrum München, a partner in the German Center for Lung Research (DZL), and their international colleagues.

An individual with COPD does not heal its own lungs anymore. Researchers are now trying to find out why.

British American Tobacco chief confident of ecigarette push

Nicandro Durante shrugs off suggestions it is playing catch-up in fast-growing market Read next BAT aims to double size of vaping business Nicandro Durante describes the market share BAT has achieved since the launch of Glo in Japan as ‘fantastic’

https://www.ft.com/content/23b177f8-f8f7-11e6-bd4e-68d53499ed71

Nicandro Durante has big plans for what is set to become the world’s largest listed tobacco company.

During his six years as chief executive, the market value of British American Tobacco has more than doubled and last month it agreed a $50bn deal to buy Reynolds American, marking the company’s return to the US after a decade’s absence.

But the Brazilian is not done yet. Last week he revealed bold plans to expand BAT’s next-generation products division, with the aim of quadrupling the number of markets in which it sells ecigarettes by 2019.

“The rate of growth is exponential,” says Mr Durante. “We’re in 12 markets now, and I want to double this in 2017, and double it again in 2018.”

Nik Oliver, consumer goods analyst at UBS, says BAT’s growth target is “relatively aggressive, but it’s feasible”, adding that the group’s “record has been very good in ecigarettes”.

While BAT is leading the market in vapour, according to Berenberg, some analysts have questioned the efficacy of its heat-not-burn tobacco product Glo.

“If BAT is going to gain any real ground [on rival Philip Morris International] the product needs to be better than IQOS [PMI’s device] in our view,” says Owen Bennett, consumer goods analyst at Jefferies.

“From trying it, we would not say this is the case.”

In addition, analysts point out that BAT’s Glo has launched only in Japan so far, while IQOS is on track to hit 35 markets, including the UK, by the end of this year.

James Bushnell, analyst at Exane BNP Paribas, says that while BAT is focused on the “more competitive” vaping market, its products “aren’t significantly better than what’s out there”.

Meanwhile, he says, it is lagging behind PMI in the tobacco-heating category.

Mr Durante rejects such criticism. He says that while the Reynolds deal will give BAT access to the US group’s reduced-risk portfolio, his group’s products are strong enough to stand alone.

“Philip Morris had a one-and-a-half year head start on us. The market shares we have been experiencing in Japan are fantastic — 5.2 per cent in nine weeks. So I don’t think that we are behind any competing products.”

Indeed, Mr Oliver at UBS describes BAT’s share in Japan as “initially very impressive”.

Mr Durante expects the Japan rollout of Glo to be completed this year and says the company is already developing new versions of the product.

The rapid expansion of IQOS has led PMI chief executive André Calantzopoulos to talk of a “smokeless future”.

But while Mr Durante expects rapid growth, he says such exuberance is premature.

“Those categories now are probably 1 or 2 per cent of the whole industry,” he says. “At the end of the day it’s all about consumer choice. Do I think that you will have a smoke-free world in my generation . . . in the next 20 years? I don’t think so.”

Mr Durante expects to continue to boost sales of traditional cigarettes in several key markets, and points to north Africa and Asia as the fastest-growing areas. “Places like Vietnam, the Philippines, and Indonesia — there are many opportunities out there,” he says.

BAT derives more than 50 per cent of its total revenues from emerging markets, according to UBS.

Mr Durante has indicated he sees further growth in north Africa and Asia, but Mr Oliver at UBS notes that while BAT has “definitely got the strongest EM portfolio of their peers”, the Reynolds deal “would definitely tilt them more towards developed markets given the huge size of the US market”.

In the US, the Reynolds deal will give BAT access to the world’s biggest vapour market.

Analysts have pointed to a further potential upside to the deal, with President Donald Trump vowing to slash corporation tax.

They warn, however, that such a move could lead Reynolds to withdraw its support for the deal on the basis that the bid substantially undervalues it, but Mr Durante is unfazed. “People just see the headline that corporation tax is going to go down,” he says. “But then you have the border tax. [It] can have a huge influence on our business in terms of the downsides,” he adds, noting that Reynolds “imports a lot of raw material”.

Assuming the Reynolds deal completes as planned by the third quarter, it will mark a milestone return to the US for a company that fled the market amid costly litigation battles over safety claims by cigarette manufacturers.

But while the industry is keen to trumpet its shift to reduced-risk products, some problems remain.

BAT has hired lawyers to examine allegations that it bribed African officials and paid a private security company to spy on and disrupt competitors on the continent.

Mr Durante pledges firm action if wrongdoing is found to have taken place. “BAT has very strong policies in this area. If there is any [wrongdoing], we are going to act and we are going to act in a very strong way.

He concedes, however: “We are in 200 countries, so I cannot give a 100 per cent guarantee that everything’s going to go by the book.”

While he refuses to be drawn on whether the lawyer’s report will be made public, insisting it is not up to BAT to decide, he stresses that BAT assures “total anonymity” to whistleblowers.

Although unsure when the report will be concluded, he is keen to see the investigation draw to a close. “As a CEO of the company I would like this to finish as soon as possible because it’s costing me a lot of money.”

Tobacco Companies Taking Over the E-Cigarette Industry

For decades, cigarettes cornered the market on nicotine.

http://www.huffingtonpost.com/entry/tobacco-companies-taking-over-the-e-cigarette-industry_us_58b48e02e4b0658fc20f98d0

People who decided to take up smoking chose the cigarette over any other nicotine delivery system available, including pipes and chewing tobacco.

This trend held true for generations of smokers, but in the past 10 years the cigarette industry has seen a small but significant sea change.

Electronic cigarettes are catching fire with an entirely new generation of smokers.

And tobacco companies have taken notice.

“It’s the most disruptive change in the tobacco market,” Jeff Drope, PhD, vice president of economic and health policy research for the American Cancer Society (ACS), told Healthline. “There is no parallel.”

A smoking hot market

Electronic nicotine delivery systems are not new.

The devices have been around in some form or another for nearly 30 years.

This current iteration of e-cigarettes made its way to the United States market by way of China.

However, the recent explosion of e-cigarette popularity caught the attention of tobacco companies a few years ago.

What was once a market populated by small independent manufacturers has given way to Big Tobacco.

And this move has anti-smoking organizations concerned.

“This is part of an ongoing strategy in the Big Tobacco playbook,” Erika Sward, assistant vice president of national advocacy for the American Lung Association (ALA), told Healthline.

The popular brand VUSE, is owned by R.J. Reynolds Vapor Company, a subsidiary of the tobacco giant Reynolds America.

British American Tobacco (BAT), the largest tobacco company in the Europe, launched Vype around four years ago.

Altria (formerly Phillip Morris) owns MarkTen.

Lorillard paid $135 million for Blu, but when R.J. Reynolds bought that tobacco company in 2015, its e-cigarette brand was sold to Imperial Tobacco, a company in the United Kingdom.

Today, global e-cigarette sales amount to around $5 billion a year.

That compares to the $92 million cigarette market, but the e-cigarette industry is expected to grow 24 percent per year through 2018.

“Big Tobacco is now dominating in dollars in sales,” Drope said.

Firms funding e-cigarette research

The tobacco industry appears so confident in the technology that they are now funding research that looks at the health effects of e-cigarettes vs. regular cigarettes.

A recent study, funded by British American Tobacco used 3-D modeling to compare the inflammation in the lungs from e-cigarettes and regular cigarettes.

The study, published in Applied In Vitro Toxicology, showed a dramatic drop in lung inflammation with e-cigarettes.

“Researchers reported changes in the expression levels of 123 genes when reconstituted lung tissue was exposed to cigarette smoke, compared to only two genes that could be confirmed following exposure to e-cigarette aerosols,” according to a press release.

These finding are similar to what initial research has uncovered about e-cigarettes. A small batch of studies do suggest that they pose less of a health threat than regular cigarettes.

“From a cancer perspective, the levels of carcinogens are lower,” Drope said.

BAT did not provide comment for this story. R.J. Reynolds also declined to be interviewed, but did provide a statement:

“We believe that vapor products and other noncombustible tobacco products may present less risk to adult tobacco consumers than smoking cigarettes. Although these products have not been used by consumers for a sufficient period of time to develop definitive scientific conclusions about their level of risk reduction, there is a growing body of scientific evidence that these products may present less risk than smoking. While some studies report that there may be health risks associated with these products, those risks appear to be lower than the risks of smoking cigarettes.”

Health concerns abound

There are many unknowns about the health hazards of e-cigarettes, and that’s what has groups such as the ALA and ACS concerned.

“Being less deadly than regular cigarettes does not make your product less safe to use,” Sward said.

First up is the use of aerosol in e-cigarettes and the impact on the body’s pulmonary and cardiovascular systems.

“We don’t know the long-term effects,” Drope said.

Aside from the health issues, the biggest concern about e-cigarettes are the users themselves.

The U.S. Surgeon General said in a report that, “among young adults 18-24 years of age, e-cigarette use more than doubled from 2013 to 2014. As of 2014, more than one-third of young adults had tried e-cigarettes.”

Sward said the trend is troubling for a number of reasons.

“There is a strong association between e-cigs, cigarettes, and other burned tobacco products by young people,” she said “There is not a safe level of nicotine use for kids until the age of 24.”

In December 2016, the FDA did establish some rules governing the sale and distribution of e-cigarettes. They can’t be sold to anyone under 18. Buyers need to show proof of identification. E-cigarettes also can’t be sold in vending machines (unless in an adult-only facility), and they can’t be distributed for free.

Both the ALA and ACS would like the FDA to impose even stricter rules, such as warning labels and an advertising ban in magazines and billboards.

“Kids are very much reacting to the advertising,” Drope said.

Sward said the flavors are another big draw to kids and the FDA hasn’t done anything to regulate those.

Both say it’s hard to tell what will happen around e-cigarettes, now that there is a new administration in the White House. Drope believes a lot depends on where the e-cigarette market industry expects to be in the next few years.

“I can imagine them being a niche market. I can see them being just another product,” he said. “If tobacco industry decides to throw their might behind it, I could really see them taking off.”

By Carolyn Abate

Vaping Is Less Terrible For You Than Cigarettes (Still Not Great For You, So Don’t Start)

Over time, people who smoke e-cigarettes seem to pile up fewer toxins in their bodies than people who smoke traditional cancer sticks.

https://www.fastcoexist.com/3068010/vaping-is-less-terrible-for-you-than-cigarettes-still-not-great-for-you-so-dont-start

Vaping devotees, you have been vindicated: In the first long-term study comparing e-cigarettes with regular old cigarettes, researchers found that e-cigs aren’t quite as bad for you as the tobacco they replace. In fact, transitioning to vaping may end up being a good way to help people quit smoking altogether.

The study, funded by Cancer Research U.K., found that people who switched from tobacco to e-cigarettes for at least six months “had much lower levels of toxic and cancer-causing substances in their body than people who continued to use conventional cigarettes.” The conclusion: e-cigarettes are less toxic than tobacco.

The study followed 181 participants over a six-month period. The participants were split into five groups: “combustible” cigarettes users, e-cigarette users, users of nicotine replacement therapy (NRT) like patches or gum, and people who smoke combustible cigarettes while also using either e-cigarettes or other NRT products.

Most studies up until now, as noted in the report, have examined the toxins in the actual vapor of the e-cigarette and compared that to the toxins in tobacco. But because the actual absorption levels of substances from e-cigarettes are not known, this may not be an accurate way to determine actual toxicity. Also, different vaping devices may deliver differing amounts of chemicals to the body.

This study instead examined the levels of toxins and carcinogens in the body over time, and found that they are lower in users of e-cigs than in regular smokers, and comparable to those found in people using other NRTs.

This is a big deal. While taking up vaping from scratch is still a bad idea, regular smokers who switch to e-cigarettes could do themselves considerably less harm than if they keep smoking tobacco. Ideally, e-cigarettes would be, like nicotine patches, used as an aid to eventually wean yourself off nicotine altogether, but even if you switch permanently to vaping, you’ll be healthier.

Vaping is still a young phenomenon—e-cigarettes were only patented in 2003—and the research is still scant. Even this study only looks at 181 individuals, and is funded by an organization that has a vested interest in reducing cancer. But really, it seems that pretty much anything is better for you than smoking. Apart from sitting down, that is.

E-cigarettes may pose the same or higher risk of stroke severity as tobacco smoke

Electronic cigarette (e-cigarettes) vaping may pose just as much or even higher risk as smoking tobacco for worsening a stroke, according to a preliminary study in mice presented at the American Heart Association’s International Stroke Conference 2017.

https://eurekalert.org/pub_releases/2017-02/aha-emp021517.php

Researchers found:

Mice exposed to e-cigarette vapor for 10 days or 30 days had worse stroke outcome and neurological deficits, than those exposed to tobacco smoke.

E-cigarette exposure decreased glucose uptake in the brain. Glucose fuels brain activity.

Both e-Cig and tobacco smoke exposure for 30 days decreased Thrombomodulin (anti-coagulant) levels.

From a brain health perspective, researchers said, electronic-cigarette vaping is not safer than tobacco smoking, and may pose a similar, if not higher risk for stroke severity.

Use of e-cigarettes is a growing health concern in both smoking and nonsmoking populations. Researchers said rigorous studies are needed to investigate the effects of the nicotine exposure via e-cigarettes on brain and stroke outcome.

Ali Ehsan Sifat, Graduate Student/Research Assistant, Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, Texas.

British American Tobacco sets sight on dominance in alternative products

Cigarette giant British American Tobacco has said its vapour business is now the largest in the world outside the US thanks to the expansion of its Vype brand.

The Dunhill and Lucky Strike owner, which is reporting its results for the year to December 31, said its vapour business had now been extended to 10 markets.

In the UK, it’s share of the vapour market is now 40pc, according to independent data from AC Nielsen, thanks to its Vype brand and acquisition of Ten Motives.

The move towards a greater reliance on alternative products – the company also launched its tobacco heating product glo in Japan in December – is becoming even more important as the growth in the consumption of conventional cigarettes stalls.

British American did manage to halt the decline in cigarette volumes it saw in 2015 but only registered a marginal 0.2pc volume rise to 665bn in 2016.

There was, however, a 0.8pc drop on an organic basis but this was better than the average 3pc decline for the industry, British American said.

The weakness of sterling benefited the company, with revenue up 12.6pc if currency movements are factored in. This is because sales in dollars translate handsomely into the now weaker pound. Sales still rose an impressive 6.9pc on a constant currency basis.

But the currency markets weren’t entirely beneficial for the group. On a constant currency basis, adjusted operating profit rose 4.1pc – a figure which would have been 10pc were it not for the “significant ongoing effect of adverse foreign exchange movements on our cost base during 2016″.

This meant underlying operating margins actually fell 0.9pc to 37.2pc if currency movements are included. Underlying operating margins rose 1.6pc excluding transactional foreign exchange and acquisitions.

Management said the proposed deal to buy the 57.8pc of Reynolds American it does not already own would give it a “world class portfolio of tobacco and Next Generation Products”, and that it would enhance earnings at the enlarged group. The transaction is expected to close during the third quarter subject to shareholder and regulatory approvals being sought. If the deal goes ahead, the company would become the world’s largest listed tobacco company by sales.

Cole-Bishop Bill Reintroduced in Congress

http://tobaccobusiness.com/cole-bishop-bill-reintroduced-congress/

By Tobacco Business –

FDA Congress

U.S. Representatives Tom Cole (R-Oklahoma) and Cole Bishop (D-Georgia) reintroduced legislation in Congress in an effort to change the FDA predicate date under the FDA tobacco regulations. Known as the FDA Deeming Clarification Act of 2017 (HR 1136), this legislation would also adopt new regulations relating to e-cigarette and vapor products. HR 1136 is an updated version of HR 2058 and the Cole/Bishop amendment.

The re-introduced bill would change the predicate date from Feb. 15, 2007 to Aug. 8, 2016, the date when the FDA deeming regulations took effect.

This move would allow newly deemed tobacco products that were on the market as of Aug. 8, 2016-including e-cigarettes, vapor, cigars, pipe tobacco, hookah tobacco, nicotine gels and dissolvable nicotine products-would not need a special Substantial Equivalency Application or Pre-Market Tobacco Application to be filed with the FDA in order to remain on store shelves and in the market. These products would still be required to comply with the other FDA tobacco regulations, however.

Specifically for vapor products, the bill would also establish a product standard for vapor product batteries. The product standard would include technical characteristics that batteries for vapor products would need to meet in order to be used in an e-cigarette or vapor product. Vapor product manufacturers, wholesalers, and retailers would not be allowed to advertise a vapor product in a newspaper, magazine, periodical or other publication except an adult publication whose readers younger than 18 years old constitute no more than 15 percent of the total readership and fewer than 2 million people younger than 18 years older.

This bill would have a major impact on various part of the tobacco industry. First, it would relieve some of the burden placed on manufacturers of varying ages and sizes. Companies founded after Feb. 15, 2007 would be able to continue operating with their products readily available in the market. As is, compliance costs could drive many newer manufacturers out of business. Second, changing the predicate date would give many manufacturers more product on the market. This also could drastically change the course of the vapor industry, much of which was established long after 2007. The vapor industry is also greatly founded in technology and the ongoing improvement and development of said technology. Anything that was on the market prior to the 2007 predicate date, which is very little, would likely not be promoted or used by vapor consumers today. There are also a great deal of questions and concerns regarding the FDA approval process for tobacco products like cigars, pipe tobacco and vapor products, which is likely to be a very long, costly and confusing process.

Many in the vapor industry view HR 1136 as the first necessary step in developing appropriate regulation for the vapor industry. On its website, the Consumer Advocates for Smoke Free Alternative Association (CASAA) commented, “Different efforts and strategies are required to keep moving the ball forward. Looking to the future, fair regulatory treatment of vapor products is part of the larger campaign to change the tobacco control culture int he United States. Ultimately, policy makers, regulators, and public health advocates must change their abstinence-only approach to one of the comprehensive harm reduction in order to humanely reduce the morbidity and mortality associated with smoking cigarettes.”

The passing of HR 1136 would be a major breakthrough for those hit by the FDA deeming ruling. You are encouraged to reach out to your state representatives and voice your support for the bill, either through email, phone or attending a town hall meeting.

Research and Markets – Asia-Pacific $840.3 Million E-cigarette and Vaporizer

The APAC e-cigarette market currently valued at 840.3 million contributes a very small percentage in the global e-cigarette market.

Despite the presence of large number of smokers in the region, the e-cigarette and vaporizer market in APAC is at a nascent stage, with a large percentage of the popular still oblivious of the product. Consortiums and associations are playing a crucial rule in increasing market penetration by promoting public education campaigns to highlight the benefits of vapor products for adult smokers and familiarize them with new products in the market and their advantages. The prominent consortiums discussed in this segment are Asian Vape Association (AVA), Fact Asia, Malaysia E-Vaporizer and Tobacco Alternatives Association (MEVTA), and Philippine E-cigarette Industry Association (PECIA) among others.

With a slack regulatory regime and deep seated smoking habit entrenched in majority of its population, APAC has massive potential to turn into the hub for e-cigarettes and related products. The report on the APAC E-cigarette Device and Aftermarket’ is a meticulous compilation of the various facets of the e-cigarette and vaporizer industry. After a thorough analysis of the current trends, the market dynamic chapter includes the key push and pull forces prevailing in the APAC e-cigarette device and aftermarket.

Owing to the dependency of the market growth on the legal and regulatory framework, the report at each step has considered the effect of laws (both implemented and anticipated) in terms of regulations and taxation in estimation and forecast of the market size. Moreover, the key consortiums and compliance influencing the e-cigarette and e-liquid market across the continent have also been included in the report.

The report involves a mix of 25 companies chosen on the basis of their market developments, revenue generation and market share in the industry. The companies profiled in the report include Just Fog, Innokin, ITC, Kimree, First Union and Joyetech among others.

Key Questions answered in the report:

– How will the key market players leverage on key developments such as acquisitions, partnerships, and product launch among others?
– How will the intensity of competitive rivalry evolve through the forecast period?
– Which factors will be driving the market through the forecast period?
– What factors are currently challenging the APAC e-cigarette device and aftermarket and how can they be addressed through the forecast period?
– Which consortiums are active in the market?
– Which compliances and certifications are necessary to make a product acceptable among the users (especially the first time vapers)?
– What are the prevalent e-liquid types and what is the market size for each of them?
– How will the aftermarket (e-liquid, atomizers, and battery) grow in the next ten years?
– Who are the key players in the E-liqid e-cigarette market?

Key Topics Covered:

Executive Summary

1 Research Scope and Methodology
1.1 Scope of the Report
1.2 APAC E-cigarette and Vaporizer Market Research Methodology

2 Market Dynamics
2.1 Market Drivers
2.1.1 High Smoking Population and Need for Tobacco Alternatives
2.1.2 Emergence of Vape Shops and Online Distribution Channels
2.1.3 Price Sensitivity And Long Term Cost Effectiveness
2.1.4 Product Innovation
2.2 Market Challenges
2.2.1 Fragmented Market and Stringent Regulatory Framework
2.2.1.1 Fragmented Market
2.2.1.2 Stringent Regulatory Framework
2.2.2 Increase in Counterfeit Products Volume
2.2.3 Unregulated Manufacturing in China

3 Competitive Insights
3.1 Key Strategies and Developments
3.2 Industry Attractiveness

4 APAC E-cigarette Industry Key Consortiums and Alliances
4.1 Asian Vape Association (AVA)
4.2 Fact Asia
4.3 Malaysia E-Vaporizers and Tobacco Alternatives Association (MEVTA)
4.4 Tobacco Free Alternatives Association of India (TFFAI)
4.5 Philippine E-Cigarette Industry Association (PECIA)

5 APAC E-cigarette and Vaporizer Market Analysis and Forecast by Market Segment
5.1 Key Assumptions for Market Estimation and Forecast
5.2 Market Overview
5.3 APAC E-cigarette and Vaporizer Device Market
5.4 The APAC E-cigarette and Vaporizer Aftermarket (Components Market), Analysis and Forecast

6 APAC E-cigarette and Vaporizer Market Analysis and Forecast, by Distribution Channel
6.1 Market Overview
6.2 Online Distribution Channel
6.3 Retail Distribution Channels
6.3.1 Convenience Stores (C-Stores)
6.3.2 Vape Shops
6.3.3 Others (Pharmacies, Drug Stores and Gas Stations)

7 APAC E-Cigarette and Vaporizer Device & Aftermarket Analysis and Forecast by Key Countries
7.1 Market Overview
7.2 China

8 Company Profile
8.1 Electronic Cigarette Just Fog Co., Ltd.
8.2 Shenzhen FirstUnion Technology Co., Ltd.
8.3 Innokin Technology Co., Ltd.
8.4 ITC Limited
8.5 Joyetech
8.6 Kanger Technology Co., LTD.
8.7 Kimree, INC
8.8 L-Rider Technology Co. Ltd.
8.9 Mistlife
8.10 Shenzhen Smoore Technology Co., Ltd.
8.11 Smokefree
8.12 Timiya Technology Co., Ltd
8.13 Top Q
8.14 Samurai Vapors Co. Ltd.
8.15 Huizhou Hangboo Biotech Co., Ltd.
8.16 Hangsen

For more information about this report visit http://www.researchandmarkets.com/research/9q3vjd/apac_ecigarette

Media Contact:

Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call 353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): 353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets—asia-pacific-8403-million-e-cigarette-and-vaporizer-device-and-aftermarket-analysis-and-forecast-2016-2025-featuring-just-fog-innokin-itc-kimree-first-union-and-joyetech-among-others-300406303.html

SOURCE Research and Markets

MENAFN1902201700701241ID1095254016